Focal Medical Technology is developing the APOLLO platform, an operator‑independent robotic system for minimally invasive, non‑thermal focal ablation of prostate cancer.

The platform features a real‑time grid for precise electrode placement, achieving very tight margins and immediate validation of the ablated area.

APOLLO delivers highly targeted, image‑guided treatment with minimal side effects, offering a safer and less invasive alternative to current prostate cancer therapies.